Trial no.:
|
PACTR201710002640828 |
Date of Approval:
|
24/09/2017 |
Trial Status:
|
Retrospective registration - This trial was registered after enrolment of the first participant |
|
TRIAL DESCRIPTION |
Public title
|
moderate ischemic mitral regurge |
Official scientific title |
MODERATE ISCHEMIC MITRAL REGURGE: REVASCULARIZATION ALONE VERSUS REVASCULARIZATION AND MITRAL VALVE REPAIR |
Brief summary describing the background
and objectives of the trial
|
Ischemic mitral regurgitation (IMR) is a common finding following myocardial infarction or ischemia. Management of moderate IMR is still a hot topic. Adding mitral valve repair (MVr) to coronary artery bypass grafting (CABG) is questionable.The goal of this study was to assess and compare short term clinical and echocardiographic results of moderate IMR treated by CABG alone versus another group of patients treated by CABG plus MVr.
|
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Cardiology,Circulatory System,mitral valve disease |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Surgery |
Anticipated trial start date |
01/01/2016 |
Actual trial start date |
02/01/2016 |
Anticipated date of last follow up |
31/12/2017 |
Actual Last follow-up date |
10/10/2017 |
Anticipated target sample size (number of participants) |
40 |
Actual target sample size (number of participants) |
40 |
Recruitment status |
Closed to recruitment,follow-up continuing |
Publication URL |
|
|